Skip to main content
Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · IEX Real-Time Price · USD
1.305
+0.025 (1.95%)
At close: Jul 2, 2024, 4:00 PM
1.310
+0.005 (0.38%)
After-hours: Jul 2, 2024, 5:53 PM EDT

Spero Therapeutics Revenue

Spero Therapeutics had revenue of $110.98M in the twelve months ending March 31, 2024, with 107.40% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $9.27M with 347.90% year-over-year growth. In the year 2023, Spero Therapeutics had annual revenue of $103.78M with 93.95% growth.

Revenue (ttm)
$110.98M
Revenue Growth
+107.40%
P/S Ratio
0.63
Revenue / Employee
$2,412,565
Employees
46
Market Cap
70.45M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023103.78M50.27M93.95%
Dec 31, 202253.51M35.25M193.10%
Dec 31, 202118.26M8.93M95.67%
Dec 31, 20209.33M-8.82M-48.59%
Dec 31, 201918.15M14.18M357.56%
Dec 31, 20183.97M1.99M100.40%
Dec 31, 20171.98M1.64M490.75%
Dec 31, 2016335.00K--
Dec 31, 20150--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

SPRO News

More News